- Home
- FNLC vs HRTX Comparison
FNLC vs HRTX Comparison
Compare FNLC & HRTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- FNLC
- HRTX
- Stock Information
- Founded
- FNLC 1864
- HRTX 1983
- Country
- FNLC United States
- HRTX United States
- Employees
- FNLC N/A
- HRTX N/A
- Industry
- FNLC Major Banks
- HRTX Biotechnology: Pharmaceutical Preparations
- Sector
- FNLC Finance
- HRTX Health Care
- Exchange
- FNLC Nasdaq
- HRTX Nasdaq
- Market Cap
- FNLC 290.8M
- HRTX 270.7M
- IPO Year
- FNLC 1999
- HRTX 1987
- Fundamental
- Price
- FNLC $25.38
- HRTX $1.73
- Analyst Decision
- FNLC
- HRTX Strong Buy
- Analyst Count
- FNLC 0
- HRTX 3
- Target Price
- FNLC N/A
- HRTX $5.67
- AVG Volume (30 Days)
- FNLC 29.6K
- HRTX 1.2M
- Earning Date
- FNLC 04-16-2025
- HRTX 02-27-2025
- Dividend Yield
- FNLC 5.67%
- HRTX N/A
- EPS Growth
- FNLC N/A
- HRTX N/A
- EPS
- FNLC 2.43
- HRTX N/A
- Revenue
- FNLC $79,740,000.00
- HRTX $137,737,000.00
- Revenue This Year
- FNLC N/A
- HRTX $13.10
- Revenue Next Year
- FNLC N/A
- HRTX $14.03
- P/E Ratio
- FNLC $10.44
- HRTX N/A
- Revenue Growth
- FNLC 0.35
- HRTX 12.13
- 52 Week Low
- FNLC $21.77
- HRTX $1.04
- 52 Week High
- FNLC $31.05
- HRTX $3.93
- Technical
- Relative Strength Index (RSI)
- FNLC 42.59
- HRTX 52.86
- Support Level
- FNLC $25.51
- HRTX $1.63
- Resistance Level
- FNLC $26.44
- HRTX $1.83
- Average True Range (ATR)
- FNLC 0.50
- HRTX 0.10
- MACD
- FNLC 0.04
- HRTX -0.01
- Stochastic Oscillator
- FNLC 11.67
- HRTX 41.94
About FNLC First Bancorp Inc (ME)
First Bancorp Inc is a Damariscotta-based bank holding company providing a range of retail and commercial banking services including deposit accounts and consumer, commercial and mortgage loans. The company provides investment management and private banking services through an operating division of the bank. Its revenues are generally derived from dividends paid to the company by the bank.
About HRTX Heron Therapeutics Inc.
Heron Therapeutics Inc is a commercial-stage biotechnology company. It is focused on improving the lives of patients by developing treatments that address some of the unmet patient needs. The company's product portfolio consists of APONVIE, SUSTOL, ZYNRELEF, and CINVANTI.